Similar articles

• Sequential TNF and TGF-beta regulation of expansion and induction of cytotoxicity in long-term cultures of lymphokine-activated killer cells.

  Koberda J, Przepiorka D, Moser RP, Grimm EE. Koberda J, et al. Lymphokine Cytokine Res. 1994 Apr;13(2):139-45. Lymphokine Cytokine Res. 1994. PMID: 8061115
• Enhancement of lymphokine-activated T killer cell tumor necrosis factor receptor mRNA transcription, tumor necrosis factor receptor membrane expression, and tumor necrosis factor/lymphotoxin release by IL-1 beta, IL-4, and IL-6 in vitro.

  Dett CA, Gatanaga M, Ininns EK, Cappuccini F, Yamamoto RS, Granger GA, Gatanaga T. Dett CA, et al. J Immunol. 1991 Mar 1;146(5):1522-6. J Immunol. 1991. PMID: 1847164
• [Cytotoxicity of human lymphokine-activated killer cells against mitotic phase tumor cells].

  Liu GR. Liu GR. Zhonghua Yi Xue Za Zhi. 1993 Sep;73(9):547-8, 576. Zhonghua Yi Xue Za Zhi. 1993. PMID: 8313200 Chinese.
• Lymphokine-activated killer lymphocytes: evidence for regulation of induction and function by multiple cytokines.

  Owen-Schaub LB, Grimm EA. Owen-Schaub LB, et al. Immunol Ser. 1989;48:19-35. Immunol Ser. 1989. PMID: 2488321 Review. No abstract available.
• Adoptive cellular immunotherapy for cancer: interleukin-2 activated lymphocytes.

  Wolf JA Jr, Grimm EA. Wolf JA Jr, et al. Curr Opin Oncol. 1989 Dec;1(2):249-57. Curr Opin Oncol. 1989. PMID: 2489968 Review. No abstract available.